ID   SMCA4_RAT               Reviewed;        1613 AA.
AC   Q8K1P7;
DT   09-FEB-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   29-MAY-2024, entry version 144.
DE   RecName: Full=Transcription activator BRG1;
DE            EC=3.6.4.-;
DE   AltName: Full=ATP-dependent helicase SMARCA4;
DE   AltName: Full=BRG1-associated factor 190A;
DE            Short=BAF190A;
DE   AltName: Full=Protein brahma homolog 1;
DE   AltName: Full=SNF2-beta;
DE   AltName: Full=SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4;
GN   Name=Smarca4; Synonyms=Baf190a, Brg1, Snf2b, Snf2l4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Hippocampus;
RA   Hirsch O., Almeida O.F.X.;
RT   "Isolation and characterization of the rat brahma related gene-1 (BRG-1).";
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, AND INTERACTION WITH SS18L1; HDAC1; RB1 AND SP1.
RX   PubMed=19081374; DOI=10.1016/j.neuron.2008.09.040;
RA   Qiu Z., Ghosh A.;
RT   "A calcium-dependent switch in a CREST-BRG1 complex regulates activity-
RT   dependent gene expression.";
RL   Neuron 60:775-787(2008).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-613; SER-695; SER-699;
RP   SER-1419; SER-1536; SER-1541; SER-1552; SER-1593 AND SER-1597, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Involved in transcriptional activation and repression of
CC       select genes by chromatin remodeling (alteration of DNA-nucleosome
CC       topology). Component of SWI/SNF chromatin remodeling complexes that
CC       carry out key enzymatic activities, changing chromatin structure by
CC       altering DNA-histone contacts within a nucleosome in an ATP-dependent
CC       manner. Component of the CREST-BRG1 complex, a multiprotein complex
CC       that regulates promoter activation by orchestrating the calcium-
CC       dependent release of a repressor complex and the recruitment of an
CC       activator complex. In resting neurons, transcription of the c-FOS
CC       promoter is inhibited by SMARCA4-dependent recruitment of a phospho-
CC       RB1-HDAC repressor complex. Upon calcium influx, RB1 is
CC       dephosphorylated by calcineurin, which leads to release of the
CC       repressor complex. At the same time, there is increased recruitment of
CC       CREBBP to the promoter by a CREST-dependent mechanism, which leads to
CC       transcriptional activation. The CREST-BRG1 complex also binds to the
CC       NR2B promoter, and activity-dependent induction of NR2B expression
CC       involves the release of HDAC1 and recruitment of CREBBP. Belongs to the
CC       neural progenitors-specific chromatin remodeling complex (npBAF
CC       complex) and the neuron-specific chromatin remodeling complex (nBAF
CC       complex). During neural development, a switch from a stem/progenitor to
CC       a postmitotic chromatin remodeling mechanism occurs as neurons exit the
CC       cell cycle and become committed to their adult state. The transition
CC       from proliferating neural stem/progenitor cells to postmitotic neurons
CC       requires a switch in subunit composition of the npBAF and nBAF
CC       complexes. As neural progenitors exit mitosis and differentiate into
CC       neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A,
CC       are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B
CC       or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF
CC       complex is essential for the self-renewal/proliferative capacity of the
CC       multipotent neural stem cells. The nBAF complex along with CREST plays
CC       a role regulating the activity of genes essential for dendrite growth.
CC       SMARCA4/BAF190A may promote neural stem cell self-renewal/proliferation
CC       by enhancing Notch-dependent proliferative signals, while concurrently
CC       making the neural stem cell insensitive to SHH-dependent
CC       differentiating cues. Acts as a corepressor of ZEB1 to regulate E-
CC       cadherin transcription and is required for induction of epithelial-
CC       mesenchymal transition (EMT) by ZEB1 (By similarity). Binds via DLX1 to
CC       enhancers located in the intergenic region between DLX5 and DLX6 and
CC       this binding is stabilized by the long non-coding RNA (lncRNA) Evf2 (By
CC       similarity). Binds to RNA in a promiscuous manner (By similarity).
CC       Binding to RNAs including lncRNA Evf2 leads to inhibition of SMARCA4
CC       ATPase and chromatin remodeling activities (By similarity).
CC       {ECO:0000250|UniProtKB:P51532, ECO:0000250|UniProtKB:Q3TKT4,
CC       ECO:0000269|PubMed:19081374}.
CC   -!- SUBUNIT: Component of the multiprotein chromatin-remodeling complexes
CC       SWI/SNF: SWI/SNF-A (BAF), SWI/SNF-B (PBAF) and related complexes. The
CC       canonical complex contains a catalytic subunit (either
CC       SMARCA4/BRG1/BAF190A or SMARCA2/BRM/BAF190B) and at least SMARCE1,
CC       ACTL6A/BAF53, SMARCC1/BAF155, SMARCC2/BAF170, and SMARCB1/SNF5/BAF47.
CC       Other subunits specific to each of the complexes may also be present
CC       permitting several possible developmental- and tissue-specific
CC       combinations. Component of the BAF complex, which includes at least
CC       actin (ACTB), ARID1A/BAF250A, ARID1B/BAF250B, SMARCA2/BRM,
CC       SMARCA4/BRG1/BAF190A, ACTL6A/BAF53, ACTL6B/BAF53B, SMARCE1/BAF57,
CC       SMARCC1/BAF155, SMARCC2/BAF170, SMARCB1/SNF5/INI1, and one or more
CC       SMARCD1/BAF60A, SMARCD2/BAF60B, or SMARCD3/BAF60C. In muscle cells, the
CC       BAF complex also contains DPF3. Component of neural progenitors-
CC       specific chromatin remodeling complex (npBAF complex) composed of at
CC       least, ARID1A/BAF250A or ARID1B/BAF250B, SMARCD1/BAF60A,
CC       SMARCD3/BAF60C, SMARCA2/BRM/BAF190B, SMARCA4/BRG1/BAF190A,
CC       SMARCB1/BAF47, SMARCC1/BAF155, SMARCE1/BAF57, SMARCC2/BAF170,
CC       PHF10/BAF45A, ACTL6A/BAF53A and actin. Component of neuron-specific
CC       chromatin remodeling complex (nBAF complex) composed of at least,
CC       ARID1A/BAF250A or ARID1B/BAF250B, SMARCD1/BAF60A, SMARCD3/BAF60C,
CC       SMARCA2/BRM/BAF190B, SMARCA4/BRG1/BAF190A, SMARCB1/BAF47,
CC       SMARCC1/BAF155, SMARCE1/BAF57, SMARCC2/BAF170, DPF1/BAF45B,
CC       DPF3/BAF45C, ACTL6B/BAF53B and actin. Component of the SWI/SNF-B (PBAF)
CC       chromatin remodeling complex, at least composed of SMARCA4/BRG1,
CC       SMARCB1/BAF47/SNF5, ACTL6A/BAF53A or ACTL6B/BAF53B, SMARCE1/BAF57,
CC       SMARCD1/BAF60A, SMARCD2/BAF60B, perhaps SMARCD3/BAF60C, SMARCC1/BAF155,
CC       SMARCC2/BAF170, PBRM1/BAF180, ARID2/BAF200 and actin. Component of
CC       SWI/SNF (GBAF) subcomplex, which includes at least BICRA or BICRAL
CC       (mutually exclusive), BRD9, SS18, SMARCA2/BRM, SMARCA4/BRG1/BAF190A,
CC       ACTL6A/BAF53, SMARCC1/BAF155, and SMARCD1/BAF60A. Component of the
CC       BAF53 complex, at least composed of BAF53A, RUVBL1,
CC       SMARCA4/BRG1/BAF190A, and TRRAP, which preferentially acetylates
CC       histone H4 (and H2A) within nucleosomes (By similarity). Component of
CC       the CREST-BRG1 complex, at least composed of SMARCA4/BRG1/BAF190A,
CC       SS18L1/CREST, HDAC1, RB1 and SP1 (By similarity). Interacts with
CC       PHF10/BAF45A (By similarity). Interacts with MYOG (By similarity).
CC       Interacts directly with IKFZ1; the interaction associates IKFZ1 with
CC       the BAF complex. Interacts with ZEB1 (via N-terminus). Interacts with
CC       NR3C1, PGR, SMARD1, TOPBP1 and ZMIM2/ZIMP7. Interacts with (via the
CC       bromodomain) with TERT; the interaction regulates Wnt-mediated
CC       signaling (By similarity). Interacts with TBX21 in a KDM6B-dependent
CC       manner (By similarity). Interacts with KDM6A and KDM6B (By similarity).
CC       Interacts with HNRNPU; this interaction occurs in embryonic stem cells
CC       and stimulates global Pol II-mediated transcription (By similarity).
CC       Interacts with ACTL6A (By similarity). Interacts with DLX1 (By
CC       similarity). Interacts with DPF2. Interacts with DPF3a (isoform 2 of
CC       DPF3/BAF45C) and with HDGFL2 in a DPF3a-dependent manner. May interact
CC       with ADNP2 (By similarity). Interacts with LETMD1 (via C-terminal); the
CC       interaction regulates transcriptional expression of thermogenic genes
CC       in brown adipose tissue (By similarity). Interacts (via KIKL motif)
CC       with BRD3 (via NET domain) (By similarity).
CC       {ECO:0000250|UniProtKB:P51532, ECO:0000250|UniProtKB:Q3TKT4}.
CC   -!- INTERACTION:
CC       Q8K1P7; G3V612: Olig2; NbExp=2; IntAct=EBI-689301, EBI-6676662;
CC       Q8K1P7; Q4KLI0: Smarcb1; NbExp=2; IntAct=EBI-689301, EBI-689316;
CC       Q8K1P7; Q12824: SMARCB1; Xeno; NbExp=2; IntAct=EBI-689301, EBI-358419;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q3TKT4}.
CC       Note=Colocalizes with long non-coding RNA Evf2 in nuclear RNA clouds
CC       (By similarity). Localizes to sites of DNA damage (By similarity).
CC       {ECO:0000250|UniProtKB:P51532, ECO:0000250|UniProtKB:Q3TKT4}.
CC   -!- DOMAIN: The KIKL motif recognizes and binds the NET domain of BRD3.
CC       {ECO:0000250|UniProtKB:P51532}.
CC   -!- SIMILARITY: Belongs to the SNF2/RAD54 helicase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ504723; CAD43278.1; -; mRNA.
DR   AlphaFoldDB; Q8K1P7; -.
DR   SMR; Q8K1P7; -.
DR   IntAct; Q8K1P7; 4.
DR   STRING; 10116.ENSRNOP00000013166; -.
DR   iPTMnet; Q8K1P7; -.
DR   PhosphoSitePlus; Q8K1P7; -.
DR   jPOST; Q8K1P7; -.
DR   PaxDb; 10116-ENSRNOP00000013166; -.
DR   UCSC; RGD:621728; rat.
DR   AGR; RGD:621728; -.
DR   RGD; 621728; Smarca4.
DR   eggNOG; KOG0386; Eukaryota.
DR   InParanoid; Q8K1P7; -.
DR   PhylomeDB; Q8K1P7; -.
DR   Reactome; R-RNO-1266695; Interleukin-7 signaling.
DR   Reactome; R-RNO-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-RNO-3214858; RMTs methylate histone arginines.
DR   Reactome; R-RNO-3247509; Chromatin modifying enzymes.
DR   Reactome; R-RNO-8939243; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known.
DR   PRO; PR:Q8K1P7; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0000791; C:euchromatin; ISO:RGD.
DR   GO; GO:0000792; C:heterochromatin; ISO:RGD.
DR   GO; GO:0001673; C:male germ cell nucleus; ISO:RGD.
DR   GO; GO:0071565; C:nBAF complex; ISS:UniProtKB.
DR   GO; GO:0071564; C:npBAF complex; ISS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005726; C:perichromatin fibrils; ISO:RGD.
DR   GO; GO:0016514; C:SWI/SNF complex; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; ISO:RGD.
DR   GO; GO:0008094; F:ATP-dependent activity, acting on DNA; ISO:RGD.
DR   GO; GO:0140658; F:ATP-dependent chromatin remodeler activity; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0070182; F:DNA polymerase binding; ISO:RGD.
DR   GO; GO:0004386; F:helicase activity; IEA:UniProtKB-KW.
DR   GO; GO:0106222; F:lncRNA binding; ISO:RGD.
DR   GO; GO:0070577; F:lysine-acetylated histone binding; ISO:RGD.
DR   GO; GO:0050681; F:nuclear androgen receptor binding; ISO:RGD.
DR   GO; GO:0002039; F:p53 binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0030957; F:Tat protein binding; ISO:RGD.
DR   GO; GO:0003713; F:transcription coactivator activity; ISO:RGD.
DR   GO; GO:0001221; F:transcription coregulator binding; ISO:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0035904; P:aorta development; ISO:RGD.
DR   GO; GO:0035887; P:aortic smooth muscle cell differentiation; ISO:RGD.
DR   GO; GO:0001832; P:blastocyst growth; ISO:RGD.
DR   GO; GO:0001835; P:blastocyst hatching; ISO:RGD.
DR   GO; GO:0001568; P:blood vessel development; ISO:RGD.
DR   GO; GO:0000902; P:cell morphogenesis; ISO:RGD.
DR   GO; GO:0006338; P:chromatin remodeling; IDA:RGD.
DR   GO; GO:0060976; P:coronary vasculature development; ISO:RGD.
DR   GO; GO:0060318; P:definitive erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0006346; P:DNA methylation-dependent heterochromatin formation; ISO:RGD.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; ISO:RGD.
DR   GO; GO:0048562; P:embryonic organ morphogenesis; ISO:RGD.
DR   GO; GO:0048730; P:epidermis morphogenesis; ISO:RGD.
DR   GO; GO:0030198; P:extracellular matrix organization; ISO:RGD.
DR   GO; GO:0030900; P:forebrain development; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0007403; P:glial cell fate determination; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0060347; P:heart trabecula formation; ISO:RGD.
DR   GO; GO:0030902; P:hindbrain development; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0030216; P:keratinocyte differentiation; ISO:RGD.
DR   GO; GO:0070307; P:lens fiber cell development; ISO:RGD.
DR   GO; GO:0001889; P:liver development; ISO:RGD.
DR   GO; GO:0060766; P:negative regulation of androgen receptor signaling pathway; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IMP:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; ISO:RGD.
DR   GO; GO:0003407; P:neural retina development; ISO:RGD.
DR   GO; GO:0022008; P:neurogenesis; ISO:RGD.
DR   GO; GO:0006337; P:nucleosome disassembly; IDA:RGD.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISO:RGD.
DR   GO; GO:0061626; P:pharyngeal arch artery morphogenesis; ISO:RGD.
DR   GO; GO:0043923; P:positive regulation by host of viral transcription; ISO:RGD.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:1902661; P:positive regulation of glucose mediated signaling pathway; ISO:RGD.
DR   GO; GO:1902895; P:positive regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:1901838; P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I; ISO:RGD.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0060319; P:primitive erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0030334; P:regulation of cell migration; ISO:RGD.
DR   GO; GO:0001188; P:RNA polymerase I preinitiation complex assembly; IEA:GOC.
DR   GO; GO:0007286; P:spermatid development; IEP:RGD.
DR   GO; GO:0019827; P:stem cell population maintenance; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045815; P:transcription initiation-coupled chromatin remodeling; ISO:RGD.
DR   GO; GO:0001570; P:vasculogenesis; ISO:RGD.
DR   GO; GO:0003281; P:ventricular septum development; ISO:RGD.
DR   CDD; cd05516; Bromo_SNF2L2; 1.
DR   CDD; cd18062; DEXHc_SMARCA4; 1.
DR   CDD; cd18793; SF2_C_SNF; 1.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 3.40.5.120; -; 1.
DR   Gene3D; 1.20.920.10; Bromodomain-like; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 3.40.50.10810; Tandem AAA-ATPase domain; 1.
DR   InterPro; IPR030100; BRG1_ATP-bd.
DR   InterPro; IPR006576; BRK_domain.
DR   InterPro; IPR037259; BRK_sf.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR018359; Bromodomain_CS.
DR   InterPro; IPR014978; Gln-Leu-Gln_QLQ.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C-like.
DR   InterPro; IPR014012; HSA_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR029295; SnAC.
DR   InterPro; IPR038718; SNF2-like_sf.
DR   InterPro; IPR049730; SNF2/RAD54-like_C.
DR   InterPro; IPR000330; SNF2_N.
DR   PANTHER; PTHR10799; SNF2/RAD54 HELICASE FAMILY; 1.
DR   PANTHER; PTHR10799:SF76; TRANSCRIPTION ACTIVATOR BRG1; 1.
DR   Pfam; PF07533; BRK; 1.
DR   Pfam; PF00439; Bromodomain; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF07529; HSA; 1.
DR   Pfam; PF08880; QLQ; 1.
DR   Pfam; PF14619; SnAC; 1.
DR   Pfam; PF00176; SNF2-rel_dom; 1.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00592; BRK; 1.
DR   SMART; SM00297; BROMO; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SMART; SM00573; HSA; 1.
DR   SMART; SM00951; QLQ; 1.
DR   SMART; SM01314; SnAC; 1.
DR   SUPFAM; SSF160481; BRK domain-like; 1.
DR   SUPFAM; SSF47370; Bromodomain; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS00633; BROMODOMAIN_1; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS51204; HSA; 1.
DR   PROSITE; PS51666; QLQ; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; ATP-binding; Bromodomain; Chromatin regulator;
KW   Helicase; Hydrolase; Isopeptide bond; Neurogenesis; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Repressor; RNA-binding;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..1613
FT                   /note="Transcription activator BRG1"
FT                   /id="PRO_0000391344"
FT   DOMAIN          171..206
FT                   /note="QLQ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01001"
FT   DOMAIN          460..532
FT                   /note="HSA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00549"
FT   DOMAIN          766..931
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          1084..1246
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   DOMAIN          1443..1513
FT                   /note="Bromo"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   REGION          1..282
FT                   /note="Necessary for interaction with SS18L1/CREST"
FT                   /evidence="ECO:0000269|PubMed:19081374"
FT   REGION          1..177
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          198..351
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          462..728
FT                   /note="RNA-binding region which is sufficient for binding
FT                   to lncRNA Evf2"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TKT4"
FT   REGION          577..610
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          647..699
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          837..916
FT                   /note="Sufficient for interaction with DLX1"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TKT4"
FT   REGION          1247..1413
FT                   /note="Sufficient for interaction with DLX1"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TKT4"
FT   REGION          1366..1427
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1530..1613
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           881..884
FT                   /note="DEGH box"
FT                   /evidence="ECO:0000250"
FT   MOTIF           1562..1565
FT                   /note="KIKL"
FT                   /evidence="ECO:0000250|UniProtKB:P51532"
FT   COMPBIAS        1..31
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        73..88
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        133..147
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        159..177
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        215..288
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        300..340
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        659..674
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        685..699
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1366..1386
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1395..1415
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1535..1552
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1553..1579
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1595..1613
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         779..786
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   SITE            1505..1506
FT                   /note="Required for binding to 'Lys-15'-acetylated histone
FT                   3"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         11
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P51532"
FT   MOD_RES         188
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P51532"
FT   MOD_RES         353
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P51532"
FT   MOD_RES         609
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P51532"
FT   MOD_RES         610
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51532"
FT   MOD_RES         613
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         626
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6DIC0"
FT   MOD_RES         695
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         699
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1349
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51532"
FT   MOD_RES         1390
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3TKT4"
FT   MOD_RES         1419
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1536
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1541
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1552
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1593
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1597
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CROSSLNK        1332
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P51532"
SQ   SEQUENCE   1613 AA;  181427 MW;  7E5F1B04D4C26C87 CRC64;
     MSTPDPPLGG TPRPGPSPGP GPSPGAMLGP SPGPSPGSAH SMMGPSPGPP SAGHPMPTQG
     PGGYPQDNMH QMHKPMESMH EKGMPDDPRY NQMKGMGMRS GAHTGMGPPP SPMDQHSQGY
     PSPLGGSEHA SSPVPASGPS SGPQMSSGPG GAPLDGSDPQ ALGQQNRGPT PFNQNQLHQL
     RAQIMAYKML ARGQPLPDHL QMAVQGKRPM PGMQQQMPTL PPPSVSATGP GPGPGPGPGP
     GPGPAPPNYS RPHGMGGPNM PPPGPSGVPP GMPGQPPGGP PKPWPEGPMA NAAAPTSTPQ
     KLIPPQPTGR PSPAPPAVPP AASPVMPPQT QSPGQPAQPA PLVPLHQKQS RITPIQKPRG
     LDPVEILQER EYRLQARIVH RIQELENLPG SLAGDLRTKA TIELKALRLL NFQRQLRQEV
     VVCMRRDTAL ETALNAKAYK RSKRQSLREA RITEKLEKQQ KIEQERKRRQ KHQEYLNSIL
     QHAKDFREYH RSVTGKLQKL TKAVATYHAN TEREQKKENE RIEKERMRRL MAEDEEGYRK
     LIDQKKDKRL AYLLQQTDEY VANLTELVRQ HKAAQVAKEK KKKKKKKKAE NAEGQTPAIG
     PDGEPLDETS QMSDLPVKVI HVESGKILTG TDAPKAGQLE AWLEMNPGYE VAPRSDSEES
     GSEEEEEEEE EEQPQPAQPP TLPVEEKKKI PDPDSDDVSE VDARHIIENA KQDVDDEYGV
     SQALARGLQS YYAVAHAVTE RVDKQSALMV NGVLKQYQIK GLEWLVSLYN NNLNGILADE
     MGLGKTIQTI ALITYLMEHK RINGPFLIIV PLSTLSNWAY EFDKWAPSVV KVSYKGSPAA
     RRAFVPQLRS GKFNVLLTTY EYIIKDKHIL AKIRWKYMIV DEGHRMKNHH CKLTQVLNTH
     YVAPRRLLLT GTPLQNKLPE LWALLNFLLP TIFKSCSTFE QWFNAPFAMT GEKVDLNEEE
     TILIIRRLHK VLRPFLLRRL KKEVEAQLPE KVEYVIKCDM SALQRVLYRH MQAKGVLLTD
     GSEKDKKGKG GTKTLMNTIM QLRKICNHPY MFQHIEESFS EHLGFTGGIV QGLDLYRASG
     KFELLDRILP KLRATNHKVL LFCQMTSLMT IMEDYFAYRG FKYLRLDGTT KAEDRGMLLK
     TFNEPGSEYF IFLLSTRAGG LGLNLQSADT VIIFDSDWNP HQDLQAQDRA HRIGQQNEVR
     VLRLCTVNSV EEKILAAAKY KLNVDQKVIQ AGMFDQKSSS HERRAFLQAI LEHEEQDEEE
     DEVPDDETVN QMIARHEEEF DLFMRMDLDR RREEARNPKR KPRLMEEDEL PSWIIKDDAE
     VERLTCEEEE EKMFGRGSRH RKEVDYSDSL TEKQWLKAIE EGTLEEIEEE VRQKKSSRKR
     KRDSEAGSST PTTSTRSRDK DEESKKQKKR GRPPAEKLSP NPPNLTKKMK KIVDAVIKYK
     DSSGRQLSEV FIQLPSRKEL PEYYELIRKP VDFKKIKERI RNHKYRSLND LEKDVMLLCQ
     NAQTFNLEGS LIYEDSIVLQ SVFTSVRQKI EKEDDSEGEE SEEEEEGEEE GSESESRSVK
     VKIKLGRKEK AQDRLKGGRR RPSRGSRAKP VVSDDDSDEE QEEDRSGSGS EED
//
